What's The BUZZ?

Market News, Products, Services, and Trends

Advertisement

Stimulant Diversion: The Blind Spot in Medication Waste

Stimulant Diversion: The Blind Spot in Medication Waste

Every diversion program has a shape, and in most US facilities that shape is opioid-shaped. Fentanyl counts. Propofol reconciliation. Morphine waste witnessed at the Pyxis. Meanwhile the Schedule II drugs that leave the cart every single day in long-term care, behavioral health and pediatrics — methylphenidate and amphetamine salts — move through the waste stream with a fraction of the scrutiny.

New Australian surveillance data suggests that blind spot is about to get more expensive. Read More >

Links Medical Products Inc.

Links Medical Products Inc. News & Announcements

Links Medical Products (LMP) is committed to delivering innovative, high-quality healthcare solutions that improve patient outcomes and support caregivers across the markets we serve. With a focus on clinical performance, reliability, and safety, our portfolio is designed to meet the evolving needs of post-acute care, pharmacy, hospice, EMS, and veterinary providers. Under the leadership of Patrick Buckley, President & CEO, LMP continues to expand its offerings and reinforce its reputation as a trusted partner in healthcare.

RXinsider Staff

Posted by: RXinsider Staff

RXinsider is a multimedia publishing and technology company offering print publications, digital platforms, events, and content creation services to the B2B pharmacy market.

SUBSCRIBE

Name
Subscription Choices
Checkboxes
Subscribe
Receive the latest news, product launches, and insights from RXinsider.

Request information from Stimulant Diversion: The Blind Spot in Medication Waste

Name
Address
Subscribe